We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Success Factors of ACHEMA 2012 Include Highest Ever International Participation

By LabMedica International staff writers
Posted on 09 Jul 2012
The 5-day ACHEMA 2012 exhibition congress for the chemical engineering, environmental protection, and biotechnology process industries (Frankfurt, Germany) concluded on June 22, after 167,000 participants learned about a broad range of products and services presented by 3,773 exhibitors on a 136,400 m² exhibition area with a very well received new layout of halls. More...


Popular exhibition groups included Pumps, Compressors, Valves and Fittings, Instrumentation, Control and Automation Techniques, Laboratory and Analytical Techniques, "Thermal, "Mechanical Processes, and Pharmaceutical, Packaging and Storage Techniques. In all fields, particular attention was devoted to the major themes of energy and bio-economics.

With a proportion of foreign exhibitors of almost 50%, coming from 56 countries, the ACHEMA was more international than ever before, reflecting that in these highly globalised industries ACHEMA is a leading event. “Globalisation does not just mean Europeans and Americans going to Asia – increasingly, Asian exhibitors and visitors are coming to Europe," noted Dr. Thomas Scheuring, CEO of DECHEMA Ausstellungs-GmbH. This was also evident in that more than 200 Chinese and 150 Indian companies presented their ranges. Still, numerous European and US companies once again also used the opportunity to present their innovations.

The congress included 900 talks and numerous events of various types. Aspects expected to occupy the process industry in the coming future included energy generation and storage, and biomass processing. Talks on materials science, bionics, and chemistry parks also met with a great response. "We made the right selection of focus topics," said Prof. Dr. Kurt Wagemann, Executive Director of DECHEMA e.V.

Exhibitors and visitors expressed high satisfaction. "It was a very successful show for us; considerably better than in 2009, even better than 2006 before the crisis happened,” said Friedbert Klefenz, Bosch Packaging Technology. Karsten Just of Bartec Holding noted, "More noticeable than the numbers is the fact that the quality of the visitors was very high." And according to the results of the visitor survey, more than 83% of the visitors judged the quality of the ACHEMA as "good“ or "very good“.

The 31st ACHEMA will take place starting June 15, 2015, in Frankfurt and the 9th AchemAsia on May 13-16, 2013, in Beijing (China).

Related Links:

ACHEMA



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.